About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Schering's Weird New Nuvaring Ad: "Don't You Have to ... Put It In ...?"

By Jim Edwards | Aug 25, 2009

Schering-Plough’s new TV commercial for Nuvaring employs a weird strategy — it features a group of women explaining the old Nuvaring commercial as it plays in the background (video below).

As Adfreak points out:

It’s sad when you have to run a commercial talking about how great your previous commercial was, only to clarify the earlier ad because obviously no one could figure out what you were selling.

Here’s how the script starts:

Woman 1: Ooh! I love this commercial!
Woman 2: Would you guys try Nuvaring?
Woman 3: I’m not even sure what it is!
Woman 2: [Explains the device in unrealistically specific terms].
Woman 1: Don’t you have to … put it in …?
Woman 2: For me, it’s easy!

It’s a matter of time before the statement “Don’t you have to … put it in?” becomes a SnorgTees shirt.

More seriously, once the gals on the sofa have talked up the product, they examine the risks — which are heard over footage from the old ad featuring women dancing in swimsuits. That’s a classic example of the Nasonex Bee distraction strategy, which may ultimately be banned by the FDA.

Nasonex is also marketed by Schering. Coincidence!

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Schering's Nuvaring Accused in Death; J&J's Ortho Evra Reveals a Worst-Case Scenario

    BNET Pharma - 204 days 12 hours 15 minutes ago

    If Schering-Plough wants to know what the future possibly holds for its Nuvaring contraceptive — accused in lawsuits of killing a woman via a thromboembolism Ref="javascript:Voting.vote( 1, '', 'pharma_1917',...

  • Schering-Plough chooses Citi as global commercial card provider

    Pharmaceutical Business Review - 341 days 12 hours 46 minutes ago

    Citi said that its wide acceptance and ability to integrate fully with Schering-Plough's internal payment and expense management systems will enable Schering-Plough to streamline its corporate, purchasing and fleet expenses. Paul Simpson, Citi's global head of wholesale card services for public sector business solutions and healthcare at Citi,...

  • MerckSchering-Plough's 16,000 job losses

    PharmaGossip - 166 days 1 hour 37 minutes ago

    Merck , the pharmaceutical group, said Wednesday that 16,000 jobs would be lost as it joined its operations with its rival Schering-Plough, the French daily La Tribune reported.

    Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash

    BNET Pharma - 5 days 10 hours 24 minutes ago

    Merck (MRK) has produced a set of numbers giving a look at the scale of the combined company with Schering-Plough. One surprise: The new company is

  • F.D.A. Allows New Remedy for Arthritis

    New York Times - 213 days 23 hours 42 minutes ago

    The new drug is a follow-up to Remicade, which is marketed in the United States by Johnson & Johnson and in Europe and in other countries by the Schering-Plough Corporation

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement